Skip to main content

escitalopram

Generic: escitalopram·Brand: Lexapro

escitalopram: 3 clinical trials tracked.

escitalopram evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about escitalopram, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (3)

A Phase IV, Longitudinal, Observational Study Examining Real-World Outcomes of Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vasomotor Symptoms

NCT06049797Registry updated 2026-06-05
Completed

Primary endpoint: Mean change from baseline to week 12 in symptom bother measured by the Menopause-Specific Quality of Life Domain (MENQoL) 1-week recall VMS domain score

Observational999 enrolledStarted 2023-11Completion 2026-0548 sites · United StatesAstellas Pharma Global Development, Inc.

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Trial to Assess the Efficacy, Safety, and Tolerability of Centanafadine Extended-release Capsules as Monotherapy or as Adjunct to SSRI in Adult Subjects With Major Depressive Disorder

NCT05536414Registry updated 2026-05-14·Phase 2
Completed

Primary endpoint: Change from baseline to Week 6 in Montgomery-Asberg Depression Rating Scale (MADRS) Total score.

InterventionalRandomizeddouble337 enrolledStarted 2022-09Completion 2025-0550 sites · United StatesOtsuka Pharmaceutical Development & Commercialization, Inc.

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

NCT03511118Registry updated 2026-02-11·N/A
Recruiting

Primary endpoint: M/P ratio

Observational1,600 targetStarted 2018-10Completion 2027-0722 sites · Canada, United StatesDuke University